Healing Challenging Wounds to Save Limbs — WinVivo Featured at Diabetic Foot Global Conference (DFCon 2013)
Silicon Valley, CALIFORNIA – March 25, 2013
Global explosion of incidents of diabetes and its complications has imposed major social and economic burdens in both developed and developing countries. In the US it has recently been revealed that the treatment of diabetes and its complications in the United States generated at least $116 billion in direct costs; and at least 33% of these costs were linked to the treatment of foot ulcers. Patients with diabetic foot ulcers require more frequent emergency department visits, are more commonly admitted to hospital, and require longer length of stays. Failure to heal diabetic foot ulcers could lead to amputation and increased mortality of the patients. Many hospitals and clinics in the US have implemented a team approach to manage diabetic foot ulcers within a given region or health care system, and their limb salvage efforts may include aggressive therapy, such as aggressive revascularization procedures and advanced wound healing modalities.
Since 10 years ago the Amputation Prevention Center of Valley Presbyterian Hospital in Los Angeles has been one of the co-founders/organizer of DFCon, the world's foremost interdisciplinary conference on amputation prevention, diabetes management, and diabetic foot and diabetic wound care. Its multidisciplinary team of physicians of podiatric medicine, endocrinology, and vascular diseases has enjoyed a reputation of saving limbs from major amputations locally in the Greater Los Angeles Area and worldwide.
One of the key features of this year's DFCon on on Mar 20- 23 is how to build an effective limb salvage team in view of the growing cost of healthcare and shrinking payment from government and private insurers. At the conference, WinVivo presented compelling clinical evidence of using the WINVIVO Wound Ointment ("WINVIVO") to heal challenging wounds, especially diabetic foot ulcers of patients with co-morbidities such as cardiovascular diseases, chronic renal failure, pulmonary hypertension, and bone infection. Some of the clinical results were obtained by the physicians at the Amputation Prevention Center of Valley Presbyterian Hospital who have used WINVIVO to successfully treat non-healing wounds of patients with critical limb ischemia, achieving complete wound closure in shorter periods of time with minimum cost compared to previous treatments with the-state-of-the-art advanced wound care modalities.
Many physicians who have attended last year's DFCon and obtained samples of WINVIVO shared their success stories of healing chronic wounds that have failed treatment with other modalities such as negative pressure wound therapy (NPWT), biologic dressings, skin grafts and substitutes. They told WinVivo that their patients were also enthusiastic about the concept of using multiple natural botanical ingredients to overcome many complex issues of chronic wound healing, and expressed their gratitude to their doctors for saving them from amputation, easing their economic burdens and improving their quality of life.
WinVivo is an innovative natural health care company based in Silicon Valley. Its international team of biomedical professionals combines the best from the East and West to develop highly efficacious advanced skin and wound care products from botanicals with their health benefits demonstrated over centuries of use in Asia and such functions further validated by modern scientific and clinical research.